VIC Technology Venture Development Establishes Medical Advisory Board

VIC’s newly formed Medical Advisory Board (MAB) provides VIC with additional domain expertise across a variety of life science disciplines. MAB members support VIC’s opportunity assessment team by reviewing new...

Letter from the CEO

It has been a year and ten months since the World Health Organization declared COVID-19 a pandemic. Despite the continuing pandemic, VIC’s business has largely returned to normal albeit with increased remote work, more...


Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Protecting Early Investors in Capital-Intensive Life Science Companies
Inside Blackstone LaunchPad at UT Southwestern Medical Center with Brad Phelan
White Paper
University Technology Licensing: Assessing the Opportunities and Negotiating Licenses
VIC 2021 Mid-Year Update Executive Summary
Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform
VIC Fellows Spotlight: Evan Goldberg, PhD
From The Corner Office
SFC Fluidics Nears FDA Submission